治疗的脂质体:朝着更好的脑准和减少毒性的方向
Zainab Lafi1, Sherine Asha2, Nisreen Asha3
1Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Al-Ahliyya Amman University, Al-Salt Road, Amman, 19328, Jordan; Pharmacological and Diagnostic Research Center, Faculty of Pharmacy, Al-Ahliyya Amman University, Al-Salt Road, Amman, 19328, Jordan.
Nanomedicine : nanotechnology, biology, and medicine
|November 5, 2025
概括
脂质体药物递送系统通过改善脑向和减少抗发作药物的副作用来治疗有前途. 进一步的研究可能会导致更个性化,更有效的治疗.
科学领域:
- 神经学 神经学
- 药理学 药理学是指药理学的学科.
- 生物技术是生物技术.
背景情况:
- 是一种慢性神经系统疾病,导致发作,认知障碍和生活质量下降.
- 传统的抗发作药物 (ASM) 面临着诸如脑透能力差,毒性和耐药性等挑战.
- 有效的发作控制对于预防长期的神经损伤至关重要.
研究的目的:
- 探索脂质体药物递送系统作为治疗的新策略.
- 要突出脂肪体如何克服传统ASM的局限性.
- 讨论发症向性脂质体输送方面的进展.
主要方法:
- 对神经系统疾病的脂质体药物输送近期进展的审查.
- 分析表面功能化和免疫脂质体的分析,以进行向的输送.
- 评估脂质体的特性,如大脑透率,溶解度,稳定性和非目标效应.
主要成果:
- 脂质体增强了中枢神经系统的向和治疗的药物疗效.
- 脂质体的表面修饰使得特定地点的输送到发性区域成为可能.
- 免疫聚体可以准与相关的神经炎症标记物.
结论:
- 脂质体药物递送为更精确和更耐受的治疗提供了一个有希望的途径.
- 制定,向特异性和临床翻译方面的挑战需要进一步调查.
- 脂肪体平台的持续开发可以显著改善个性化的管理.
相关概念视频
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
804
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
804
Antiepileptic Drugs: Glutamate Antagonists
880
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
880
Epilepsy and Seizures: Overview
1.1K
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.1K
Antiepileptic Drugs: Calcium Channel Blockers
1.1K
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
1.1K
Antiepileptic Drugs: GABAergic Pathway Potentiators
1.2K
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.2K
Antiepileptic Drugs: Sodium Channel Blockers
1.6K
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
1.6K


